Lataa...
Darolutamide For Castration-Resistant Prostate Cancer
The treatment landscape of advanced prostate cancer continues to evolve rapidly, with newer and more active drugs being used in earlier phases of the disease based on improved overall survival. After adoption of docetaxel for metastatic castration-sensitive disease, large trials with next-generation...
Tallennettuna:
| Julkaisussa: | Onco Targets Ther |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6816030/ https://ncbi.nlm.nih.gov/pubmed/31695432 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S197244 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|